A publication referencing linaclotide was released on September 23, 2026. The article, titled "Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes," appeared in the journal Drugs.
The publication is indexed under PubMed ID 42773320. It is described as an update covering clinical progress in the pharmacotherapy of irritable bowel syndrome with constipation in pediatric patients, an area in which linaclotide is included among the therapies discussed.
This entry reflects the existence and title of the publication as recorded. No specific findings, outcomes, or clinical results from the article are detailed here. Readers interested in the substance of the review should consult the original source directly for its full content and conclusions.
Linaclotide remains an approved compound, and this publication represents a new addition to the literature discussing its role in a defined clinical context. No efficacy or safety conclusions should be drawn from this brief alone, as only the publication's existence, title, journal, and date are confirmed at this time.
For more background on linaclotide, including its approved uses and general profile, see the compound overview.